- Home
- LUMN vs MRUS Comparison
LUMN vs MRUS Comparison
Compare LUMN & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUMN
- MRUS
- Stock Information
- Founded
- LUMN 1968
- MRUS 2003
- Country
- LUMN United States
- MRUS Netherlands
- Employees
- LUMN N/A
- MRUS N/A
- Industry
- LUMN Telecommunications Equipment
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- LUMN Telecommunications
- MRUS Health Care
- Exchange
- LUMN Nasdaq
- MRUS Nasdaq
- Market Cap
- LUMN 5.1B
- MRUS 5.1B
- IPO Year
- LUMN 1972
- MRUS 2016
- Fundamental
- Price
- LUMN $5.92
- MRUS $68.80
- Analyst Decision
- LUMN Buy
- MRUS Strong Buy
- Analyst Count
- LUMN 7
- MRUS 13
- Target Price
- LUMN $5.12
- MRUS $90.92
- AVG Volume (30 Days)
- LUMN 15.7M
- MRUS 542.5K
- Earning Date
- LUMN 11-04-2025
- MRUS 10-30-2025
- Dividend Yield
- LUMN N/A
- MRUS N/A
- EPS Growth
- LUMN N/A
- MRUS N/A
- EPS
- LUMN N/A
- MRUS N/A
- Revenue
- LUMN $12,824,000,000.00
- MRUS $56,228,000.00
- Revenue This Year
- LUMN N/A
- MRUS $57.42
- Revenue Next Year
- LUMN N/A
- MRUS $0.23
- P/E Ratio
- LUMN N/A
- MRUS N/A
- Revenue Growth
- LUMN N/A
- MRUS 59.77
- 52 Week Low
- LUMN $3.01
- MRUS $33.19
- 52 Week High
- LUMN $10.33
- MRUS $70.41
- Technical
- Relative Strength Index (RSI)
- LUMN 67.84
- MRUS 60.56
- Support Level
- LUMN $4.57
- MRUS $65.74
- Resistance Level
- LUMN $6.65
- MRUS $70.65
- Average True Range (ATR)
- LUMN 0.41
- MRUS 2.38
- MACD
- LUMN 0.13
- MRUS 0.07
- Stochastic Oscillator
- LUMN 64.90
- MRUS 81.37
About LUMN Lumen Technologies Inc.
With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 in 2017 and divestiture of much of its incumbent local exchange carrier, or ILEC, business in 2022 have shifted the company's operations away from its legacy consumer business and toward enterprises (now about 75% of revenue). Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen has announced the sale of its consumer fiber network, but will maintain and harvest its legacy consumer copper network.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.